Enter your terms above and click the 'Search' button.

Showing articles 0 to 2 of 2 Filter Applied: risk-benefit assessment (Click to remove) GLP-1s:Novo Nordisk and Eli Lilly Face Laswsuit Over Vision Loss andw Eye Damage BMJ 395:e101099, Cozzolino,A., 2026 Visual Field Constriction in Children Treated with Vigabatrin Neurol 52:1713-1714,1537, Vanhatalo,S.&Paakkonen,L., 1999 Showing articles 0 to 2 of 2